Roche Statement Regarding Tamiflu U.S. Labe...(ropriate post-marketingmonitoring and re...),Health
Navigation Links
Roche Statement Regarding Tamiflu U.S. Label Revision
Date:3/4/2008
ropriate post-marketing monitoring and research.
For full U.S. prescribing information, please visit http://www.tamiflu.com.
'/>"/>
| SOURCE Roche Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Neurochem announces departure of two members of management team
2. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
3. Press Statement: Roche Affirms That Tamiflu(R) is in Ample Supply Nationwide
4. Roche Completes Tender Offer for Ventana Shares
5. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
6. Roche Purchases Shares in Tender Offer for Ventana
7. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
8. Roche Plans to Complete Ventana Offer on February 7th
9. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
10. Rochester Medical Announces First Quarter 2008 Earnings Conference Call February 4, 2008
11. Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in Worlds Poorest Countries
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 2Health News:Tweaks to Breast Cancer Treatments Boost Outcomes 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 2Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 3Health News:Effort to Regenerate Injured Spinal Cords Turns to a New Model 4Health News:Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France 2
[0] Medicare Report Confirms Health Care Takeover Plan is a Fiscal Disaster[0] Tweaks to Breast Cancer Treatments Boost Outcomes[0] Stem Cells Turned Into AIDS Killers in Lab Tests[0] Effort to Regenerate Injured Spinal Cords Turns to a New Model[0] Alcohol Countermeasure Systems Penetrates New Markets Through Acquisition of Seres Ethylometre of France
Other Medicine News:Health News:Biologically Women Are More Vulnerable To HIV Infection 2Health News:Heart disease: Men Are From Mars, Women From Venus 2
Crucial steps taken by the Chinese government to protect its grasslandsWhirlpool Bath Tubs Contain Potentially Lethal Bacterial StrainsBiologically Women Are More Vulnerable To HIV InfectionHeart disease: Men Are From Mars, Women From VenusCome September, Schools Will be better off Sans Junk foodsAvastin, anti-Cancer Drug leads to Blindness and Other Complications
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call 5276 1Gene Test Might Predict Tamoxifens Effectiveness 58993 1Gene Test Might Predict Tamoxifens Effectiveness 58993 2Gene Test Might Predict Tamoxifens Effectiveness 58993 3Keeping DNA all in the family 10277 1Keeping DNA all in the family 10277 2Keeping DNA all in the family 10277 3
Other Medicine Technology:Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |